| scholarly article | Q13442814 |
| P50 | author | Paul C. Driscoll | Q30502295 |
| Acely Garza-Garcia | Q58183137 | ||
| P2093 | author name string | Birger Herzog | |
| Malini Menon | |||
| Snezana Djordjevic | |||
| Haiyan Jia | |||
| Ian Zachary | |||
| Mark Stewart | |||
| Chris Chapman | |||
| Lili Cheng | |||
| Basil Hartzoulakis | |||
| Katie Ellard | |||
| Rehan Aqil | |||
| David L Selwood | |||
| Ashley Jarvis | |||
| Charles K Allerston | |||
| James Nally | |||
| Michelle Tickner | |||
| Natalie Winfield | |||
| Rosemary Lynch | |||
| P2860 | cites work | Blocking neuropilin-1 function has an additive effect with anti-VEGF to inhibit tumor growth | Q24293042 |
| Crystal structure of the human neuropilin-1 b1 domain | Q27640286 | ||
| Structural basis for ligand and heparin binding to neuropilin B domains | Q27644336 | ||
| Coot: model-building tools for molecular graphics | Q27860505 | ||
| The CCPN data model for NMR spectroscopy: development of a software pipeline | Q27860601 | ||
| PRODRG: a tool for high-throughput crystallography of protein-ligand complexes | Q27860633 | ||
| The finer things in X-ray diffraction data collection | Q27860660 | ||
| NMRPipe: a multidimensional spectral processing system based on UNIX pipes | Q27860859 | ||
| Phasercrystallographic software | Q27860930 | ||
| Refinement of macromolecular structures by the maximum-likelihood method | Q27861011 | ||
| Reaching for high-hanging fruit in drug discovery at protein-protein interfaces | Q29547258 | ||
| Semaphorins command cells to move | Q36325591 | ||
| Predicting protein druggability | Q36352932 | ||
| Overexpression of neuropilin-1 promotes constitutive MAPK signalling and chemoresistance in pancreatic cancer cells | Q36615085 | ||
| Neuropilins: structure, function and role in disease. | Q37117907 | ||
| Anti-VEGF therapy as adjuvant therapy: clouds on the horizon? | Q37277105 | ||
| Cytotoxic synergy between the multikinase inhibitor sorafenib and the proteasome inhibitor bortezomib in vitro: induction of apoptosis through Akt and c-Jun NH2-terminal kinase pathways | Q40229775 | ||
| Characterization of a Bicyclic Peptide Neuropilin-1 (NP-1) Antagonist (EG3287) Reveals Importance of Vascular Endothelial Growth Factor Exon 8 for NP-1 Binding and Role of NP-1 in KDR Signaling | Q58449597 | ||
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | endothelium | Q111140 |
| drug discovery | Q1418791 | ||
| P304 | page(s) | 2215-26 | |
| P577 | publication date | 2010-03-11 | |
| P1433 | published in | Journal of Medicinal Chemistry | Q900316 |
| P1476 | title | Small molecule inhibitors of the neuropilin-1 vascular endothelial growth factor A (VEGF-A) interaction | |
| P478 | volume | 53 |
| Q38842975 | A modified thymosin alpha 1 inhibits the growth of breast cancer both in vitro and in vivo: suppressment of cell proliferation, inducible cell apoptosis and enhancement of targeted anticancer effects |
| Q36962800 | Ablation of Neuropilin 1 from glioma-associated microglia and macrophages slows tumor progression |
| Q58736493 | Addressing the Issues of Non-isotropy and Non-additivity in the Development of Quantum Chemistry-Grounded Polarizable Molecular Mechanics |
| Q28482295 | Anti-tumor activity of a novel HS-mimetic-vascular endothelial growth factor binding small molecule |
| Q36312850 | Antitumor activity of Triolimus: a novel multidrug-loaded micelle containing Paclitaxel, Rapamycin, and 17-AAG. |
| Q37864564 | Application of NMR methods to the study of the interaction of natural products with biomolecular receptors. |
| Q50070927 | Architecture and Hydration of the Arginine Binding Site of Neuropilin-1. |
| Q35826030 | Autocrine VEGF-VEGFR2-Neuropilin-1 signaling promotes glioma stem-like cell viability and tumor growth |
| Q107098522 | Cnicin as an Anti-SARS-CoV-2: An Integrated In Silico and In Vitro Approach for the Rapid Identification of Potential COVID-19 Therapeutics |
| Q58736657 | Conformational analysis of a polyconjugated protein-binding ligand by joint quantum chemistry and polarizable molecular mechanics. Addressing the issues of anisotropy, conjugation, polarization, and multipole transferability |
| Q48201168 | Conformational latitude - activity relationship of KPPR tetrapeptide analogues toward their ability to inhibit binding of vascular endothelial growth factor 165 to neuropilin-1. |
| Q27027713 | Control of cellular motility by neuropilin-mediated physical interactions |
| Q27728194 | Crystal Structure of the Neuropilin-1 MAM Domain: Completing the Neuropilin-1 Ectodomain Picture |
| Q92770779 | Discovery of a novel fluorescent chemical probe suitable for evaluation of neuropilin-1 binding of small molecules |
| Q34842279 | Effect of C-terminal sequence on competitive semaphorin binding to neuropilin-1 |
| Q101133458 | Epigenetic targeting of neuropilin-1 prevents bypass signaling in drug-resistant breast cancer |
| Q41556287 | Exogenous recombinant dimeric neuropilin-1 is sufficient to drive angiogenesis |
| Q38056998 | Function of members of the neuropilin family as essential pleiotropic cell surface receptors. |
| Q42374239 | Genetic status of KRAS modulates the role of Neuropilin-1 in tumorigenesis |
| Q37958931 | How neuropilin-1 regulates receptor tyrosine kinase signalling: the knowns and known unknowns |
| Q42773855 | Mechanistic basis for the potent anti-angiogenic activity of semaphorin 3F |
| Q33678067 | Microplate-based screening for small molecule inhibitors of neuropilin-2/vascular endothelial growth factor-C interactions |
| Q84736698 | Molecular mechanisms of tumor angiogenesis |
| Q53055054 | N-terminal modification of VEGF-A C terminus-derived peptides delineates structural features involved in neuropilin-1 binding and functional activity. |
| Q93233474 | NRP-1 interacts with GIPC1 and SYX to activate p38 MAPK signaling and cancer stem cell survival |
| Q88654151 | NRP-1 interacts with GIPC1 and α6/β4-integrins to increase YAP1/∆Np63α-dependent epidermal cancer stem cell survival |
| Q26765952 | NRP1 function and targeting in neurovascular development and eye disease |
| Q92646184 | NRP1 promotes cell migration and invasion and serves as a therapeutic target in nasopharyngeal carcinoma |
| Q38672213 | NRP1 transport of cancer therapeutics mediated by tumor-penetrating peptides |
| Q24318367 | Neuropilin 1 (NRP1) hypomorphism combined with defective VEGF-A binding reveals novel roles for NRP1 in developmental and pathological angiogenesis |
| Q36057518 | Neuropilin 1 expression correlates with the Radio-resistance of human non-small-cell lung cancer cells |
| Q38165001 | Neuropilin 1: function and therapeutic potential in cancer |
| Q38187496 | Neuropilin regulation of angiogenesis, arteriogenesis, and vascular permeability |
| Q38532037 | Neuropilin-1 as Therapeutic Target for Malignant Melanoma. |
| Q100750026 | Neuropilin-1 is a host factor for SARS-CoV-2 infection |
| Q104440536 | Neuropilin-1 is a host factor for SARS-CoV-2 infection |
| Q89312213 | Neuropilin-1 upregulation elicits adaptive resistance to oncogene-targeted therapies |
| Q89587291 | Neuropilin: Handyman and Power Broker in the Tumor Microenvironment |
| Q64252020 | Neuropilins Controlling Cancer Therapy Responsiveness |
| Q38040614 | Neuropilins are multifunctional coreceptors involved in tumor initiation, growth, metastasis and immunity |
| Q64275592 | Neuropilins in the Context of Tumor Vasculature |
| Q38161356 | Neuropilins: a new target for cancer therapy |
| Q37699218 | Nordihydroguaiaretic acid impairs prostate cancer cell migration and tumor metastasis by suppressing neuropilin 1. |
| Q38022543 | Plexin structures are coming: opportunities for multilevel investigations of semaphorin guidance receptors, their cell signaling mechanisms, and functions |
| Q34586211 | Production of soluble human vascular endothelial growth factor VEGF-A165-heparin binding domain in Escherichia coli |
| Q41791347 | Quantification and cell-to-cell variation of vascular endothelial growth factor receptors. |
| Q35050210 | Rationale for targeting VEGF, FGF, and PDGF for the treatment of NSCLC |
| Q99637393 | SARS-CoV-2 Spike protein co-opts VEGF-A/Neuropilin-1 receptor signaling to induce analgesia |
| Q100427774 | SARS-CoV-2 Spike protein co-opts VEGF-A/Neuropilin-1 receptor signaling to induce analgesia |
| Q52592095 | Small Molecule Neuropilin-1 Antagonists Combine Antiangiogenic and Antitumor Activity with Immune Modulation through Reduction of Transforming Growth Factor Beta (TGFβ) Production in Regulatory T-Cells. |
| Q30385802 | Structural studies of neuropilin-2 reveal a zinc ion binding site remote from the vascular endothelial growth factor binding pocket |
| Q91995955 | Synchronous inhibition of mTOR and VEGF/NRP1 axis impedes tumor growth and metastasis in renal cancer |
| Q35584958 | Targeting angiogenesis in esophagogastric adenocarcinoma |
| Q38044691 | The chemistry and biology of organic guanidine derivatives. |
| Q38256958 | The emerging role of class-3 semaphorins and their neuropilin receptors in oncology |
| Q64988358 | Triazolopeptides Inhibiting the Interaction between Neuropilin-1 and Vascular Endothelial Growth Factor-165. |
| Q42937806 | Tuftsin signals through its receptor neuropilin-1 via the transforming growth factor beta pathway |
| Q47168995 | Tumor-penetrating Peptide Conjugated and Doxorubicin Loaded T1-T2 Dual Mode MRI Contrast Agents Nanoparticles for Tumor Theranostics |
| Q47918409 | VEGF as a potential target in lung cancer |
| Q28240025 | VEGF binding to NRP1 is essential for VEGF stimulation of endothelial cell migration, complex formation between NRP1 and VEGFR2, and signaling via FAK Tyr407 phosphorylation |
| Q38800006 | VEGF-A acts via neuropilin-1 to enhance epidermal cancer stem cell survival and formation of aggressive and highly vascularized tumors. |
| Q34491119 | Vasculogenic mimicry of HT1080 tumour cells in vivo: critical role of HIF-1α-neuropilin-1 axis |
| Q38043064 | siRNA delivery: from lipids to cell-penetrating peptides and their mimics |
Search more.